bsm, yes, Roslin would have a "bank" of cells that can be purchased for research or commercialization. If commercialized then "Commercialization licenses will also provide access to the cell lines biologics master file in order to establish regulatory compliance. If set up the way the PR describes these cell lines would be ready to go straight from the lab into clinical trials. Remember also that currently no FED funding would be available using these cell lines although it does remove the ethical issue for some institutions.
News 
Market Data 
Discover 
AI
